Lisa M. Orme

Lisa M. Orme is a female healthcare provider who specializes in treating various conditions such as Febrile Neutropenia, Agranulocytosis, Infantile Neutropenia, Adult Soft Tissue Sarcoma, Embryonal Tumor with Multilayered Rosettes, Ewing Sarcoma, and Osteosarcoma.

Lisa M. Orme helps patients by using her special skills and treatments to care for them when they are sick. She is good at explaining things clearly and listening to patients' concerns. Patients trust her because she is kind, knowledgeable, and always puts their well-being first.

To make sure she provides the best care, Lisa M. Orme stays updated with the latest medical knowledge and research. This helps her give patients the most effective treatments based on the newest information available.

Lisa M. Orme works well with other medical professionals and values teamwork. She collaborates with colleagues to ensure that patients receive comprehensive care and the best possible outcomes. Her positive relationships with other healthcare providers contribute to a supportive and effective work environment.

Through her dedication and expertise, Lisa M. Orme has made a positive impact on many patients' lives. Her compassionate care and commitment to excellence have helped improve the health and well-being of those she treats.

One of Lisa M. Orme's notable publications is "Further case and literature review of the novel epithelioid vascular bone lesion associated with NFATC1/2 fusions" in the journal Pathology. She is also involved in a clinical trial called "A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor." This trial aims to find new ways to treat this type of cancer in young patients.

Overall, Lisa M. Orme is a dedicated healthcare provider who uses her expertise and compassion to help patients and contribute to advancing medical knowledge through research and clinical trials.